Related Experiment Video
Updated: May 26, 2026

Systematic Bronchoscopy: the Four Landmarks Approach
Published on: June 23, 2023
Treatable traits in paediatric bronchiectasis: current practice and a proposed checklist
Joséphine Annereau1,2, Apolline Gonsard1,3, Rola Abou Taam1
1Department of Paediatric Pulmonology and Allergology, AP-HP, University Hospital Necker-Enfants Malades, 149, rue de Sèvres, F-75015, Paris, France.
Insights
In children with non-cystic fibrosis bronchiectasis (NCFB), clinical assessments missed half of treatable traits (TTs), especially behavioral factors. A new checklist aims to improve structured assessment in routine care for NCFB patients.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
Background:
- Pediatric non-cystic fibrosis bronchiectasis (NCFB) management is individualized due to disease heterogeneity.
- A treatable traits (TT) approach offers precision medicine beyond standard guidelines.
Purpose of the Study:
- To evaluate the routine documentation of treatable traits (TTs) in children with NCFB.
- To identify gaps in the assessment of TTs in clinical practice.
- To propose a checklist for structured TT assessment in NCFB.
Main Methods:
- Retrospective study of children (<18 years) with CT-confirmed NCFB at a tertiary center (2010-2024).
- Assessed documentation of 41 predefined TTs across aetiological, pulmonary, extrapulmonary, and behavioural/environmental domains.
- Determined which TTs were assessed and identified per patient.
Main Results:
- Only 49% of 41 TTs were documented as assessed per patient among 121 children.
- Aetiological and pulmonary traits were more frequently assessed than extrapulmonary and behavioural traits.
- Psychosocial factors (anxiety, depression) and viral prevention were never documented; treatment adherence was rarely recorded.
Conclusions:
- Half of TTs were not routinely assessed in pediatric NCFB care, particularly psychosocial and behavioral aspects.
- A pragmatic TT checklist is proposed to guide structured, traceable assessment in routine NCFB care.
Abstract:
We recently published a treatable traits (TT) framework for children with non-cystic fibrosis bronchiectasis (NCFB). Whether these traits are routinely documented as assessed and identified in clinical practice is unknown. We conducted a retrospective study of children (< 18 years) with CT-confirmed NCFB followed at a tertiary referral centre (2010-2024). For each patient, we determined which of 41 predefined TTs across four domains-aetiological (n = 6), pulmonary (n = 15), extrapulmonary (n = 9), and behavioural/environmental (n = 11)-were documented as assessed, and among those assessed, which were identified. Among 121 children (median age 10.1 years; median 2 exacerbations/year), only 20 out of 41 TTs (49%) were documented as assessed per patient, and a median of 6 were identified. Aetiological and pulmonary traits were more frequently documented as assessed than extrapulmonary and behavioural. Anxiety and depression in children or parents, as well as viral prevention measures, were never documented, and treatment adherence was rarely recorded. When traits were documented as assessed, several were frequently identified: neutrophilic inflammation was found in 93%, eosinophilic inflammation in 35%, and short-acting beta-agonist overuse in 47% of assessed patients.
Conclusion:
Even in a tertiary referral centre, half of TTs lacked documented assessment in children with NCFB, particularly psychosocial and behavioural factors. Based on these findings, we propose a pragmatic TT checklist, used as a flexible clinical guide, to support structured, clinically relevant, and traceable assessment of children with NCFB in routine care.
What Is Known:
• Paediatric non-cystic fibrosis bronchiectasis is a heterogeneous disease requiring individualised management. • A "treatable traits" approach has been proposed to guide precision medicine beyond standard guidelines.
What Is New:
• In real-life paediatric practice, only half of treatable traits are documented as assessed, with psychosocial and behavioural factors particularly infrequently documented. • We propose a pragmatic checklist to support structured, clinically guided assessment and improve routine care.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration can...
Chronic Obstructive Pulmonary Disease-I: Introduction